Skip to content
MRKMerck & Co. Inc.

MRK Earnings

Merck & Co. Inc. next reports earnings on October 29, 2026. Track record: 4/4 beats.

Next Earnings In

43Days
:
13Hours
:
10Min
:
28Sec

Thursday, October 29, 2026

Current Price

$143.79

EPS Estimate

Earnings Per Share

$2.21

-14.3% YoY

Trailing EPS

Last 12 months earnings

$1.25

Beat Rate

4/4

100%

Forward P/E

Price-to-Earnings ratio

15.1

Margin: 4.8%

Analyst Rating

Buy

26 analysts

Analyst Sentiment

Buy26 analysts
Target: $152.96+6.4%Full analysis →

Earnings History

4/4 Beats
QuarterEPS Est.EPS ActualSurpriseResult
2026-06-30-$0.26-$0.13+49.4%Beat
2026-03-31-$1.47-$1.28+13.1%Beat
2025-12-31$2.01$2.04+1.5%Beat
2025-09-30$2.35$2.58+9.9%Beat

Growth Estimates

PeriodEPS Est.Growth
Current Qtr(0q)$2.21-14.3%
Next Qtr(+1q)$1.95-4.2%
Current Year(0y)$2.75-69.4%
Next Year(+1y)$9.55+247.9%

Next Quarter Estimates

EPS Estimate

Earnings Per Share

$2.21

Revenue Estimate

$17.4B

Annual EPS Est.

$2.75

-69.4% YoY

MRK Earnings FAQ

When is MRK's next earnings date?

Merck & Co. Inc. (MRK) is expected to report earnings on October 29, 2026. The consensus EPS estimate is $2.21.

Does MRK usually beat earnings estimates?

Merck & Co. Inc. has beaten Wall Street EPS estimates in 4 of the last 4 quarters (100% beat rate).

What is MRK's trailing EPS?

Merck & Co. Inc.'s trailing twelve-month EPS is $1.25. This is calculated from the last four quarters of reported earnings.

What do analysts think about MRK?

26 Wall Street analysts cover Merck & Co. Inc.. The consensus rating is "Buy" with an average price target of $152.96, implying 6.4% upside from the current price.